Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

China lifts ban on Fonterra whey powders

China lifts ban on Fonterra whey powders introduced after botulism scare

By Fiona Rotherham

Oct. 31 (BusinessDesk) - Chinese authorities have lifted a temporary ban on the importation of Fonterra Cooperative Group's whey powder and dairy base powder used in the manufacture of infant formula that has been in place since August last year in the wake of the dairy company's botulism scare.

At the time, Fonterra chief executive Theo Spierings said he was confident the suspension could be lifted within 48 hours. Fonterra is refusing further comment on the move which was announced by the Ministry for Primary Industries.

A ban by Russia imposed at the same time on the same products remains in place.

The temporary suspension accounted for a third of New Zealand’s dairy exports to China. Fonterra, is responsible for 90 percent of the country’s dairy exports to China.

The temporary ban didn’t impact whole milk powder and skim milk powder although at the time China also increased inspection and supervision of all New Zealand dairy products at the border. It also didn’t affect imports of infant milk formula that had already been blended.

The whey powder is used in a variety of products while the whey-based dairy base powder is sold to third-party manufacturers who turn it into infant formula.

Units in the Fonterra Shareholders' Fund, which gives investors exposure to Fonterra's dividend stream, were unchanged at $6.29, and have gained 8.5 percent this year.

(BusinessDesk)

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Business Headlines | Sci-Tech Headlines

 
GenPro: General Practices Begin Issuing Clause 14 Notices

GenPro has been copied into a rising number of Clause 14 notices issued since the NZNO lodged its Primary Practice Pay Equity Claim against General Practice employers in December 2023.More

SPADA: Screen Industry Unites For Streaming Platform Regulation & Intellectual Property Protections

In an unprecedented international collaboration, representatives of screen producing organisations from around the world have released a joint statement.More

 
 
 
 
 
 
 
 
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.